Publications:

Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Cells

Smorodinsky-Atias, Karina K; Soudah, Nadine N; Engelberg, David D

Publication Date: 2020-01-06

Variant appearance in text: ERK1: S219P

PubMed Link: 31935908

Variant Present in the following documents:

• Main text
• cells-09-00129.pdf

View BVdb publication page

Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Cell

Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R

Publication Date: 2015-09-24

Variant appearance in text: MAPK3: S219P

PubMed Link: 26388441

Variant Present in the following documents:

• mmc4.xlsx, sheet 1

View BVdb publication page

ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.

Cancer Research

Goetz, Eva M EM; Ghandi, Mahmoud M; Treacy, Daniel J DJ; Wagle, Nikhil N; Garraway, Levi A LA

Publication Date: 2014-12-01

Variant appearance in text: ERK1: S219P

PubMed Link: 25320010

Variant Present in the following documents:

• Main text

View BVdb publication page